← SynDRA
DACINOSTAT
SynDRA canonical compound SYN0004827 — structure-anchored drug synonym record
Clinical phase
Phase 1
Primary target(s)
HDAC1 | HDAC2 | HDAC3 | HDAC4 | HDAC5 | HDAC6 | HDAC7 | HDAC8 | HDAC9
Mechanism of action
HDAC inhibitor
All known targets
HDAC1
HDAC2
HDAC3
HDAC4
HDAC5
HDAC6
HDAC7
HDAC8
HDAC9
Mechanisms of action (all sources)
histone deacetylase inhibitor
HDAC1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
HDAC10
HDAC11
CYP3A4
KCNH2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
COMT
GAMT
GNMT
HLAB
HNMT
IFNB1
IFNG
KSYK
NNMT
NSD2
PARP1
PNMT
SYK
Cross-references
PubChem CID:
6445533
ChEMBL:
CHEMBL356066
DrugBank:
DB17034
ChEBI:
94063
TTD: D0B3FV
Synonyms
Laq-824
LAQ824
NVP-LAQ824
LAQ-824
LAQ824 (Dacinostat)
UNII-V10P524501
(E)-N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide
CHEMBL356066
V10P524501
(2E)-N-hydroxy-3-[4-({(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
Dacinostat [INN]
(E)-N-Hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]meth yl]phenyl]prop-2-enamide
(2E)-N-hydroxy-3-(4-{[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl}phenyl)prop-2-enamide
NVP-LAQ 824
NVP-LAQ824, Dacinostat, LAQ824
LBH539
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
Dacinostat (NVP-LAQ824, LAQ824)
(2e)-n-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide
LAQ824 (NVP-LAQ824,Dacinostat)
(2E)-N-Hydroxy-3-(4-(((2-hydroxyethyl)(2-(1H-indol-3-yl)ethyl)amino)methyl)phenyl)propenamide
(2E)-N-Hydroxy-3-(4-({(2-hydroxyethyl)(2-(1H-indol-3-yl)ethyl)amino}methyl)phenyl)propenamide
2-Propenamide, N-hydroxy-3-(4-(((2-hydroxyethyl)(2-(1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)-
DACINOSTAT [WHO-DD]
SCHEMBL95240
MLS006010418
MLS006011098
SCHEMBL181782
GTPL7497
LAQ824,NVP-LAQ824
BDBM19428
CHEBI:94063
DTXSID50870351
BCP01747
EX-A2226
ZINC1494627
MFCD09970778
s1095
AKOS015899788
Look up DACINOSTAT in the interactive SynDRA portal →